Insmed Inc (INSM)
69.69
+0.73
(+1.06%)
USD |
NASDAQ |
Apr 25, 16:00
70.00
+0.31
(+0.44%)
After-Hours: 20:00
Insmed Max Drawdown (5Y): 63.30% for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Baxter International Inc | 66.47% |
| Biomarin Pharmaceutical Inc | 53.26% |
| Amicus Therapeutics Inc | 74.97% |
| Ardelyx Inc | 95.65% |
| BridgeBio Pharma Inc | 92.80% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 16.88 |
| Beta (5Y) | 1.072 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 81.30% |
| Historical Sharpe Ratio (5Y) | 0.4184 |
| Historical Sortino (5Y) | 1.485 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.99% |